Entero Healthcare Solutions Limited Share Price & Analysis
₹1599.00+1.32%Updated 28 Oct 2026, 03:30 pm IST
LTP
₹1599.00+1.32%Open
₹1552.60High
₹1609.40Low
₹1541.80Close
₹1599.0052W High
₹1920.0052W Low
₹944.00Volume
96KLot Size
1Sector
Consumer ServicesMarket Cap
₹6K CrFace Value
₹10Mid Cap
Price Chart
Candle
Range
Fundamentals
P/E
49.50Sector P/E
55.90P/B
—EPS
₹28.82ROE
6.94%ROCE
10.50%D/E Ratio
0.40Div Yield
0.00%Book Value
₹388.00Strengths
- Low debt relative to equity (D/E 0.4x)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| ETERNAL ETERNAL LIMITED | ₹326 | ₹3.1L Cr | 621 | 10.06 | 0.38 | 2.48 | 0.18 |
| DMART Avenue Supermarts Limited | ₹3,134 | ₹2.1L Cr | 66.1 | 7.83 | 12.9 | 17.2 | 0.16 |
| TRENT Trent Limited | ₹2,914 | ₹1.5L Cr | 79.5 | 22.24 | 27.7 | 28.3 | 0.37 |
| INDHOTEL The Indian Hotels Company Limited | ₹805 | ₹1.1L Cr | 55.4 | 8.41 | 14.2 | 17.1 | 0.25 |
| LENSKART Lenskart Solutions Limited | ₹— | ₹1.1L Cr | 166 | — | 6.33 | 8.08 | 0.45 |
| MEESHO Meesho Limited | ₹— | ₹99K Cr | — | — | -46.2 | -40 | 0.01 |
| NYKAA FSN E-Commerce Ventures Limited | ₹343 | ₹91K Cr | 344 | 68.23 | 15.3 | 17.2 | 1.01 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
ENTERO · as of Mar 2026
Promoters52.42%
FII17.21%2.71pp
DII10.19%0.56pp
Public20.19%2.16pp
| Category | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoters | 52.44% | 52.44% | 52.44% | 52.44% | 52.42% | 52.42% |
| FII | 23.30% | 23.32% | 23.82% | 22.20% | 19.92% | 17.21% |
| DII | 2.28% | 2.06% | 7.73% | 8.78% | 9.63% | 10.19% |
| Public | 21.99% | 22.18% | 16.02% | 16.59% | 18.03% | 20.19% |
Corporate Events
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Results3 Nov 2026
To consider and approve the financial results for the period ended March 31, 2026 and other business matters
Results24 May 2026
Latest News
All newsEntero Healthcare to host analyst and investor meet
*Entero Healthcare to host analyst and investor meet.* The company has announced a schedule for its upcoming analyst and institutional investor meet, details of which will be shared in due course. The event aims to provide updates on business performance and strategy. No financial disclosures or major announcements were revealed. 📊 *STOCKS:* $ENTERO | 🏢 *SECTOR:* Healthcare | #LOWIMPACT #InvestorMeet
NSE Filing22 Sept
Entero Healthcare publishes notice via newspaper
*Entero Healthcare publishes notice via newspaper.* The company has issued a notice through newspaper publication as part of a regulatory requirement. Such filings are routine and typically relate to shareholder communications or statutory disclosures. No immediate financial impact is expected. 📊 *STOCKS:* ENTEROHEALTH | 🏢 *SECTOR:* CapitalMarkets | #LOWIMPACT #corporate_filing
NSE Filing28 Jul
Financials
Quarterly Results
| Metric | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹1.7K Cr 8.7% | ₹1.6K Cr 11.9% | ₹1.4K Cr 4.9% | ₹1.3K Cr 1.5% | ₹1.4K Cr 4.5% | ₹1.3K Cr 18.6% | ₹1.1K Cr 6.1% | ₹1.0K Cr |
| Op. Profit | ₹68 Cr 9.7% | ₹62 Cr 24.0% | ₹50 Cr 2.0% | ₹49 Cr 2.0% | ₹50 Cr 19.0% | ₹42 Cr 40.0% | ₹30 Cr 3.4% | ₹29 Cr |
| OPM | 4.0% 0.0% | 4.0% 11.1% | 3.6% 0.0% | 3.6% 2.7% | 3.7% 12.1% | 3.3% 10.0% | 3.0% 0.0% | 3.0% |
| Net Profit | ₹34 Cr 8.1% | ₹37 Cr 23.3% | ₹30 Cr 3.2% | ₹31 Cr 6.9% | ₹29 Cr 11.5% | ₹26 Cr 23.8% | ₹21 Cr 0.0% | ₹21 Cr |
| EPS (₹) | 6.35 12.5% | 7.26 13.6% | 6.39 8.3% | 5.9 0.9% | 5.85 7.7% | 5.43 17.5% | 4.62 4.1% | 4.82 |
Values in ₹ Cr · Source: Screener.in
Annual Profit & Loss
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | ₹6.6K Cr 29.3% | ₹5.1K Cr 29.9% | ₹3.9K Cr 18.8% | ₹3.3K Cr 30.8% | ₹2.5K Cr 42.2% | ₹1.8K Cr 31.3% | ₹1.4K Cr |
| Expenses | ₹6.3K Cr 28.5% | ₹4.9K Cr 29.2% | ₹3.8K Cr 17.7% | ₹3.2K Cr 29.5% | ₹2.5K Cr 42.1% | ₹1.8K Cr 32.6% | ₹1.3K Cr |
| Op. Profit | ₹266 Cr 54.7% | ₹172 Cr 53.6% | ₹112 Cr 75.0% | ₹64 Cr 166.7% | ₹24 Cr 60.0% | ₹15 Cr 34.8% | ₹23 Cr |
| OPM | 4.0% 17.6% | 3.4% 17.2% | 2.9% 52.6% | 1.9% 90.0% | 1.0% 25.0% | 0.8% 52.9% | 1.7% |
| Other Income | ₹11 Cr 71.8% | ₹39 Cr 178.6% | ₹14 Cr 133.3% | ₹6 Cr 50.0% | ₹4 Cr 63.6% | ₹11 Cr 120.0% | ₹5 Cr |
| Interest | ₹54 Cr 28.6% | ₹42 Cr 36.4% | ₹66 Cr 34.7% | ₹49 Cr 69.0% | ₹29 Cr 45.0% | ₹20 Cr 53.8% | ₹13 Cr |
| Depreciation | ₹43 Cr 38.7% | ₹31 Cr 24.0% | ₹25 Cr 4.2% | ₹24 Cr 20.0% | ₹20 Cr 25.0% | ₹16 Cr 33.3% | ₹12 Cr |
| PBT | ₹179 Cr 28.8% | ₹139 Cr 286.1% | ₹36 Cr 1000.0% | ₹-4 Cr 80.0% | ₹-20 Cr 81.8% | ₹-11 Cr 375.0% | ₹4 Cr |
| Tax % | 19.0% 17.4% | 23.0% 291.7% | -12.0% 106.0% | 201.0% 310.2% | 49.0% 16.7% | 42.0% 37.3% | 67.0% |
| Net Profit | ₹146 Cr 36.4% | ₹107 Cr 167.5% | ₹40 Cr 463.6% | ₹-11 Cr 62.1% | ₹-29 Cr 93.3% | ₹-15 Cr 1600.0% | ₹1 Cr |
| EPS (₹) | 26.44 21.3% | 21.79 142.4% | 8.99 132.0% | -28.12 63.8% | -77.71 95.0% | -1,550.9 1753.2% | 93.81 |
| Div Payout | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Values in ₹ Cr · Source: Screener.in
Balance Sheet
| Item | Mar 2026 | Sep 2025 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|---|
Liabilities | ||||||||
| Equity Capital | ₹44 Cr 0.0% | ₹44 Cr 0.0% | ₹44 Cr 2.3% | ₹43 Cr 975.0% | ₹4 Cr 0.0% | ₹4 Cr 3900.0% | ₹0.1 Cr 0.0% | ₹0.1 Cr |
| Reserves | ₹1.6K Cr 4.5% | ₹1.7K Cr 2.5% | ₹1.7K Cr 5.4% | ₹1.6K Cr 2284.9% | ₹-73 Cr 17.7% | ₹-62 Cr 93.8% | ₹-32 Cr 100.0% | ₹-16 Cr |
| Borrowings | ₹677 Cr 52.8% | ₹443 Cr 15.1% | ₹385 Cr 13.9% | ₹338 Cr 69.3% | ₹1.1K Cr 13.0% | ₹974 Cr 35.3% | ₹720 Cr 19.4% | ₹603 Cr |
| Other Liabilities | ₹1.2K Cr 92.2% | ₹642 Cr 8.3% | ₹593 Cr 60.7% | ₹369 Cr 34.2% | ₹275 Cr 31.0% | ₹210 Cr 42.9% | ₹147 Cr 9.3% | ₹162 Cr |
| Total Liabilities | ₹3.6K Cr 26.3% | ₹2.9K Cr 5.5% | ₹2.7K Cr 15.3% | ₹2.3K Cr 79.3% | ₹1.3K Cr 16.3% | ₹1.1K Cr 34.6% | ₹836 Cr 11.6% | ₹749 Cr |
Assets | ||||||||
| Fixed Assets | ₹958 Cr 52.8% | ₹627 Cr 12.2% | ₹559 Cr 93.4% | ₹289 Cr 7.8% | ₹268 Cr 2.3% | ₹262 Cr 38.6% | ₹189 Cr 1.6% | ₹186 Cr |
| CWIP | ₹2 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr 100.0% | ₹1 Cr 50.0% | ₹2 Cr 0.0% | ₹2 Cr |
| Investments | ₹130 Cr 94.0% | ₹67 Cr 15.5% | ₹58 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other Assets | ₹2.5K Cr 16.3% | ₹2.2K Cr 3.5% | ₹2.1K Cr 1.4% | ₹2.1K Cr 97.7% | ₹1.0K Cr 20.5% | ₹863 Cr 33.8% | ₹645 Cr 15.2% | ₹560 Cr |
| Total Assets | ₹3.6K Cr 26.3% | ₹2.9K Cr 5.5% | ₹2.7K Cr 15.3% | ₹2.3K Cr 79.3% | ₹1.3K Cr 16.3% | ₹1.1K Cr 34.6% | ₹836 Cr 11.6% | ₹749 Cr |
Values in ₹ Cr · Source: Screener.in
Cash Flow Statement
| Item | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Operating CF | ₹96 Cr 224.7% | ₹-77 Cr 108.1% | ₹-37 Cr 17.8% | ₹-45 Cr 28.6% | ₹-35 Cr 49.3% | ₹-69 Cr 86.5% | ₹-37 Cr |
| Investing CF | ₹-302 Cr 230.2% | ₹232 Cr 133.0% | ₹-704 Cr 1336.7% | ₹-49 Cr 69.8% | ₹-162 Cr 422.6% | ₹-31 Cr 84.7% | ₹-203 Cr |
| Financing CF | ₹124 Cr 267.6% | ₹-74 Cr 108.6% | ₹863 Cr 1082.2% | ₹73 Cr 65.4% | ₹211 Cr 137.1% | ₹89 Cr 59.0% | ₹217 Cr |
| Net Cash Flow | ₹-82 Cr 200.0% | ₹82 Cr 32.8% | ₹122 Cr 681.0% | ₹-21 Cr 250.0% | ₹14 Cr 227.3% | ₹-11 Cr 52.2% | ₹-23 Cr |
| Free Cash Flow | ₹29 Cr 133.3% | ₹-87 Cr 112.2% | ₹-41 Cr 19.6% | ₹-51 Cr 13.3% | ₹-45 Cr 42.3% | ₹-78 Cr 3.7% | ₹-81 Cr |
Values in ₹ Cr · Source: Screener.in
Key Ratios History
| Metric | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|---|
| Debtor Days | 67d 13.6% | 59d 3.5% | 57d 0.0% | 57d 5.6% | 54d 8.0% | 50d 20.6% | 63d |
| Inventory Days | 52d 0.0% | 52d 20.9% | 43d 4.9% | 41d 16.3% | 49d 9.3% | 54d 5.3% | 57d |
| Days Payable | 45d 45.2% | 31d 29.2% | 24d 4.0% | 25d 13.6% | 22d 0.0% | 22d 31.3% | 32d |
| Cash Conv. Cycle | 74d 7.5% | 80d 3.9% | 77d 5.5% | 73d 9.9% | 81d 1.2% | 82d 6.8% | 88d |
| Working Capital Days | 35d 46.2% | 65d 35.4% | 48d 50.0% | 32d 22.0% | 41d 24.1% | 54d 5.3% | 57d |
| ROCE | 10.0% 11.1% | 9.0% 28.6% | 7.0% 40.0% | 5.0% 400.0% | 1.0% 0.0% | 1.0% | — |
Source: Screener.in · Lower days = better efficiency
About Entero Healthcare Solutions Limited
Incorporated in 2018, Entero Healthcare Solutions Ltd is in the business of distribution and marketing of pharmaceutical and surgical products and allied services[1]
Consumer ServicesRetailing
Related Analysis
Frequently Asked Questions
What is Entero Healthcare Solutions Limited share price today?
Entero Healthcare Solutions Limited (ENTERO) is currently trading at ₹1,599 on NSE, up 1.32% as of the last market session. Prices update daily after market close on MarketNetra.
Is Entero Healthcare Solutions Limited available in F&O (Futures & Options)?
Yes, Entero Healthcare Solutions Limited (ENTERO) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Entero Healthcare Solutions Limited 52-week high and low?
Entero Healthcare Solutions Limited's 52-week high is ₹1,920 and the 52-week low is ₹944. The current price of ₹1,599 is 16.7% below the 52W high.
What is Entero Healthcare Solutions Limited P/E ratio?
Entero Healthcare Solutions Limited's current P/E ratio is 49.5. This indicates the market is paying ₹49.5 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Entero Healthcare Solutions Limited options?
Entero Healthcare Solutions Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade ENTERO options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.